Access Statistics for Johann Matthias Graf von der Schulenburg

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Cost of Poor Adherence to Anti-Hypertensive Therapy in Europe 0 1 1 24 1 2 2 124
Cost of poor adherence to anti-hypertensive therapy in five European countries 0 0 0 0 0 2 5 44
Grundlagen und Methoden von GKV-Routinedatenstudien 0 0 0 21 2 4 6 108
Total Working Papers 0 1 1 45 3 8 13 276

Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Affirmative and silent cyber coverage in traditional insurance policies: Qualitative content analysis of selected insurance products from the German insurance market 0 0 1 14 2 4 11 137
Amortization of gene replacement therapies: A health policy analysis exploring a mechanism for mitigating budget impact of high-cost treatments 0 0 0 5 2 5 8 18
An Urban Crisis Management System for Critical Infrastructures: Participation Possibilities for Insurance Companies 0 0 1 13 0 0 1 84
Analysis of Driving Factors of Willingness to Use and Willingness to Pay for Existing Pharmacological Smoking Cessation Aids Among Young and Middle-Aged Adults in Germany 0 0 1 2 0 2 3 32
Benefit assessment in Germany: implications for price discounts 0 0 0 5 0 0 3 39
Bonus options in health insurance by Peter Zweifel. Awer Academic Publishers, Dordrecht, 1992. No. of ges: xii + 141. ISBN 0‐7923‐1722‐X 1 1 1 3 2 2 2 10
COVID-19: not the time for health economists? A plea for more proactive health economic involvement 0 0 1 4 0 0 1 17
Cancer management and reimbursement aspects in Germany: an overview demonstrated by the case of colorectal cancer 0 0 0 25 0 0 1 105
Commentary 0 0 0 0 1 2 3 19
Corporate Management of Highly Dynamic Risks: Evidence from the Demand for Terrorism Insurance in Germany 0 0 1 19 1 2 6 59
Correction to: An Urban Crisis Management System for Critical Infrastructures: Participation Possibilities for Insurance Companies 0 0 0 1 0 2 2 15
Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in Germany 0 0 0 2 0 2 4 55
Costs and treatment patterns of incident ADHD patients - a comparative analysis before and after the initial diagnosis - 0 0 0 1 1 1 2 24
Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study 0 0 0 5 1 2 3 76
Diffusion of innovations: treatment of Alzheimer's disease in Germany 0 0 0 39 0 1 1 192
Digital Transformation in Back-Offices of German Insurance Companies 0 4 11 25 2 11 35 70
EJHE has an official impact factor of 1.337 0 0 0 10 0 1 2 118
Editor’s note 0 0 0 2 0 0 0 16
Entwicklung der Leistungsempfängerzahlen in der Gesetzlichen Pflegeversicherung - Zum Einfluss unterschiedlicher Morbiditätsannahmen auf die Entwicklung der sozialrechtlich anerkannten Pflegebedürftigkeit in Deutschland 0 1 1 11 0 1 4 39
German Value Set for the EQ-5D-5L 0 0 0 5 0 1 5 50
German health care system in transition 0 0 0 13 1 3 3 54
Greetings from the Editors 0 0 0 2 1 1 2 26
HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies 0 0 2 18 1 3 9 106
Impact of radiofrequency ablation for patients with varicose veins on the budget of the German statutory health insurance system 0 0 0 6 1 1 2 47
Impact of the Introduction of the Social Long-Term Care Insurance in Germany on Financial Security Assessment in Case of Long-Term Care Need&ast 0 0 1 24 0 1 3 146
Letter from the editors 0 0 0 3 0 3 3 19
Measuring economic consequences of preterm birth - Methodological recommendations for the evaluation of personal burden on children and their caregivers 0 0 0 6 0 1 1 53
Measuring patients’ priorities using the Analytic Hierarchy Process in comparison with Best-Worst-Scaling and rating cards: methodological aspects and ranking tasks 0 0 0 2 1 1 3 21
Nach welchen ökonomischen Methoden sollten Gesundheitsleistungen in Deutschland evaluiert werden? / According to Which Economic Methods Should Health Care Services Become Evaluated in Germany? 0 0 0 13 0 1 3 104
On the Impact of the Financial Crisis on the Dividend Policy of the European Insurance Industry 0 0 0 227 1 2 4 823
Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany 0 0 0 6 1 1 2 71
Promoting vaccinations - an analysis of measures taken by German statutory health insurers 0 0 0 8 0 3 4 44
Rare is frequent and frequent is costly: rare diseases as a challenge for health care systems 0 1 1 7 0 2 4 32
Regional differences in health care of patients with inflammatory bowel disease in Germany 0 0 0 5 0 0 1 44
Reinsurance Brokers and Advice Quality: Is There a Need for Regulation&quest 0 0 0 21 0 0 1 155
Reliability of Risk Management: Market Insurance, Self-Insurance and Self-Protection Reconsidered 0 0 1 47 0 0 1 163
Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe 0 0 0 4 1 2 3 38
Validating the EQ-5D with time trade off for the German population 0 0 1 31 0 0 2 120
Voting on Social Security: The Family as Decision‐Making Unit 0 0 0 3 0 1 2 6
“Market withdrawals” of medicines in Germany after AMNOG: a comparison of HTA ratings and clinical guideline recommendations 0 0 0 5 1 2 7 46
Total Journal Articles 1 7 24 642 21 67 157 3,293

logo

LogEc Home

Top Working Papers
Top Journal Articles
Top Books
Top Chapters
Top Software Items

Top Authors

Top Working Paper series and Journals

About LogEc

Authors with papers registered in the RePEc Author Service.

Register yourself as an author or register more papers in the RePEc Author Service.

Authors with no registered papers

RePEc
LogEc provides access and usage statistics for services based on the RePEc data set.

Örebro UniversityLogEc is hosted by the Örebro University School of Business.

Questions or comments? Please see our explanation of how the statistics are collected or e-mail

Statistics updated 2025-12-06